title: Corticosteroids inhibit endotoxin-induced lung lymph neutrophil stimulating activity in sheep.
abstract: The Adult Respiratory Distress Syndrome (ARDS) most frequently is the result of sepsis. Accumulation of neutrophils in lung interstitium is a well-documented phenomenon, but the nature of their presence remains obscure. We hypothesized that endotoxin causes the release of substances into lung lymph that activate neutrophils and that methylprednisolone may prevent sequestration and activation of neutrophils. We used the sheep lung lymph fistula-endotoxin model of ARDS to test this hypothesis. Unanesthetized animals were given either 0.5 microgram/kg of E. coli endotoxin intravenously alone or, on a different experimental day, an identical dose of endotoxin preceded by a 1 gm bolus of methylprednisolone plus a 1 gm/hr continuous infusion. Endotoxin infusion caused the release of substances into lung lymph that were capable of stimulating normal sheep neutrophils to aggregate, migrate, and release superoxide. This activity appeared within 1 hour of endotoxin and persisted for at least 4 hours. Pretreatment by methylprednisolone did not prevent the early activity but did significantly reduce such activity 3-4 hours after endotoxin, when the permeability defects caused by endotoxin are most pronounced. We speculate that endotoxin-stimulated production of humoral neutrophil-activating substances in the lung may play a role in the pathogenesis of acute lung injury.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
authors.forename: W D
authors.initials: WD
authors.lastname: Lucht
authors.forename: G R
authors.initials: GR
authors.lastname: Bernard
authors.forename: B
authors.initials: B
authors.lastname: Butka
authors.forename: K L
authors.initials: KL
authors.lastname: Brigham
mesh_terms: D000818:Animals; D002449:Cell Aggregation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D004731:Endotoxins / Q000037:antagonists & inhibitors*; D004926:Escherichia coli; D007262:Infusions, Intravenous; D008168:Lung / Q000187:drug effects* / Q000276:immunology; D008196:Lymph / Q000187:drug effects* / Q000276:immunology; D008775:Methylprednisolone / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D012756:Sheep; D013481:Superoxides / Q000096:biosynthesis
chemical_list: D004731:Endotoxins; D013481:Superoxides; D008775:Methylprednisolone